Immunex Company

Immunex Corporation develops, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders.
Technology: Immunotherapy
Industry: PharmTech
Headquarters: Seattle, Washington, United States
Founded Date: 1981
Estimated Revenue: $10M to $50M

Visit Website
investor.relations@amgen.com
Register and Claim Ownership